AXGN - Axogen Inc logo

AXGN

Axogen Inc

Rev 1983xtop 1%20Y
Compare AXGN Hold

Axogen, Inc. develops and commercializes technologies for peripheral nerve regeneration and repair. Its products include nerve grafts, connectors, and protectors, primarily serving hospitals and surgical centers, focusing on the needs of specialized surgeons.

โš•๏ธ Healthcare NASDAQ Listed 1990 $ USD
$1,000 invested 30 years ago โ†’$5,698today

Score Overview

1 Year
Score
Net Growth-113.64%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth11.53%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score5.2
Net Growth-24.32%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth97.22%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth-132.79%
Net Trend40%
Net Income Consistency
Rev Growth6x
Rev TrendEvery year
Revenue Consistency
20 Years
Score3.3
Net Growth-89x
Net Trend30%
Net Income Consistency
Rev Growth1983x
Rev Trend89%
Revenue Consistency
30 Years
Score
Net Growth-53x
Net Trend37%
Net Income Consistency
Rev Growth19x
Rev Trend71%
Revenue Consistency
All Time
Score
Net Growth-37x
Net Trend33%
Net Income Consistency
Rev Growth31x
Rev Trend71%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Axogen Inc has ranked, year by year

Measure
Fundamentals Window

Showing 20 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • AXGN

2011: 99.8% ยท 2021: 93.0% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 43.36โ€”
1 Year2025-09-26
$ 17.16152.68%
5 Years2021-09-28
$ 15.99171.17%
10 Years2016-09-28
$ 8.86389.39%
20 Years2006-09-28
$ 0.27161x
30 Years1996-09-27
$ 7.61469.82%
All Time1990-03-27
$ 3.3612x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 251M-$ 33M$ 94M
2025$ 225M-$ 15M$ 35M
2024$ 187M-$ 9M$ 33M
2023$ 159M-$ 21M$ 31M
2022$ 138M-$ 28M$ 48M
2021$ 127M-$ 26M$ 84M
2020$ 112M-$ 23M$ 103M
2019$ 106M-$ 29M$ 96M
2018$ 83M-$ 22M$ 116M
2017$ 60M-$ 10M$ 36M
2016$ 41M-$ 14M$ 30M
2015$ 27M-$ 13M$ 25M
2014$ 16M-$ 17M$ 8M
2013$ 10M-$ 14M$ 20M
2012$ 7M-$ 9M$ 13M
2011$ 4M-$ 9M$ 8M
2010$ 91.27K-$ 1M$ 7M
2009$ 15M$ 15M
2008$ 72.71K-$ 1M$ 332.85K
2007$ 100.43K-$ 748.98K$ 832.92K
2006$ 126.66K-$ 367.18K$ 1M
2005$ 443.35K-$ 530.61K$ 1M
2004$ 1M$ 2M$ 2M
2003$ 7M-$ 1M$ 483.84K
2002$ 6M-$ 2M$ 671.59K
2001$ 15M$ 1M$ 1M
2000$ 14M-$ 2M$ 100.17K
1999$ 12M-$ 1M$ 1M
1998$ 12M-$ 400K$ 1M
1997$ 12M-$ 2M$ 700K
1996$ 13M-$ 600K$ 800K
1995$ 14M$ 200K$ 800K
1994$ 14M$ 200K
1993$ 10M$ 600K$ 800K
1992$ 9M$ 700K$ 400K
1991$ 8M$ 1M$ 200K
IPO1990$ 8M$ 900K$ 100K
AXGN - Axogen Inc logo

Axogen Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 112M to $ 225M and net income went from -$ 23M to -$ 15M. Revenue increased in every one of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 27M to $ 225M and net income went from -$ 13M to -$ 15M. Revenue increased in every one of those 10 years; net income in 4.

Axogen Inc currently holds a 20-year HDB Score of 3.3 out of 10. How the HDB Score is calculated.

Membership

Continue AXGNโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies